Chief, Adult Bone Marrow Transplant Service; Melvin Berlin Family Chair in Multiple Myeloma.
Dr. Sergio Giralt's research focus is on stem cell transplantation for patients with blood disorders. He specializes in conditioning regimens for older or more debilitated patients with blood cancers. Before this discovery, older patients with these diseases were rarely considered candidates for stem cell transplantation procedures using donor cells because of the toxic effects of high-dose chemotherapy. The development of these less intense and less toxic regimens has allowed us to perform transplants for older patients in a safe and effective manner and has changed the standard of care throughout the world. The pioneering T cell depletion techniques developed at Memorial Sloan Kettering have dramatically reduced the risk of graft-versus-host disease, a serious complication of donor stem cell transplantation. Disease recurrence after transplantation remains an important cause of treatment failure, and he is a proponent of post-transplant maintenance therapies using a variety of targeted therapies, which we are continuing to explore at Memorial Sloan Kettering.
years treating myeloma: 21
Number of Myeloma Patients Treated Annually: 500+
Details & contact info
York Avenue Manhattan
New York City, NY, United States, 10128
Phone: 212-639-2000 or 212-639-5153
Send a message to Sergio Giralt, MD